Re-evaluation of over-the-counter histamine H1-receptor antagonists based on their effects on murine models of allergen-induced nasal hyperresponsiveness

J Pharmacol Sci. 2022 Dec;150(4):275-278. doi: 10.1016/j.jphs.2022.10.004. Epub 2022 Oct 14.

Abstract

T cells play an essential role in the development of allergen-induced nasal hyperresponsiveness (NHR), a pathophysiological response in allergic rhinitis. The effects of histamine H1-receptor antagonists (antihistamines) on murine NHR models were investigated. Intragastric epinastine, fexofenadine, and loratadine administration suppressed allergen-induced immediate nasal response but not NHR in immunized mice. Regardless of the alleviation of stimulation-induced Th2 cytokine expression by loratadine and desloratadine in vitro, allergen-induced NHR and nasal eosinophil infiltration in Th2 cell-transferred mice were unaffected by loratadine in vivo. This influence on T cell-mediated NHR was excluded from the pharmacological effects of antihistamines.

Keywords: CD4(+) T cell; Mouse; Over-the-counter medicine.

MeSH terms

  • Allergens
  • Animals
  • Disease Models, Animal
  • Histamine
  • Histamine H1 Antagonists* / pharmacology
  • Loratadine* / pharmacology
  • Loratadine* / therapeutic use
  • Mice

Substances

  • Histamine H1 Antagonists
  • Loratadine
  • Allergens
  • Histamine